心脏手术血管麻痹综合征的病因、预测因素与治疗:叙述性综述
该叙述性综述总结了心脏手术(尤其涉及体外循环)后血管麻痹综合征的病理生理、危险因素、预测与诊疗进展。术后血管麻痹与发病率和死亡率增加相关;目前无正式定义,通常表现为全身血管阻力低而心脏指数维持或升高,对液体或血管升压药治疗抵抗。文章汇总了术前、术中危险因素及多模式血管升压药治疗策略。
要点
- 心脏手术后血管麻痹表现为低全身血管阻力、心脏指数维持或升高,对液体和升压药抵抗。
- 术前危险因素包括高龄、男性、高体重指数、心衰、慢性肾病、贫血、感染性心内膜炎等。
- 术中危险因素包括体外循环、输血和体温控制不佳;多模式血管升压药方案是治疗方向。
核心结论
- 心脏手术后血管麻痹综合征与发病率和死亡率增加相关,目前无正式定义,以低全身血管阻力伴心脏指数维持或升高且对液体或血管升压药抵抗为特征。
研究设计与样本
- 叙述性综述,总结心脏手术后血管麻痹的病理生理、危险因素、预测、诊断和治疗进展。
主要发现
- 术前危险因素包括患者人口学特征(高龄、男性、高体重指数)、合并症(射血分数降低的心衰、慢性肾病、贫血、感染性心内膜炎、血流动力学不稳定、甲状腺功能障碍、糖尿病、吸烟)、用药(肾素-血管紧张素-醛固酮轴阻滞剂、钙通道阻滞剂、β受体阻滞剂、正性肌力药、抗血小板和抗凝药、胺碘酮、利尿剂、麻醉药)及手术类型。
- 术中危险因素包括体外循环使用、血制品输注和体温控制不佳。
- 多种生物标志物和动态监测系统正在被研究作为血管麻痹的预测因素。
- 文章概述了现有治疗及支持其用于多模式血管升压药方案的最新证据。
临床怎么用
- 临床应识别心脏手术后血管麻痹的高危患者(结合术前合并症、用药和术中体外循环、输血等因素)。
- 治疗上可考虑多模式血管升压药方案,并关注正在研究的生物标志物和动态监测系统用于预测。
局限性
- 本文为叙述性综述,未提供系统检索策略或定量合并分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vasoplegia is a form of distributive shock that commonly occurs after cardiac surgery involving cardiopulmonary bypass. Although a formal definition does not exist, it is generally characterized by low systemic vascular resistance with a maintained or elevated cardiac index that tends to be resistant to treatment with fluid or vasopressor. Postoperative vasoplegia in cardiac surgery patients is associated with increased morbidity and mortality. This article reviews the current understanding of the pathophysiology of vasoplegia in cardiac surgery, including risk factors for its development, and evolving strategies for prediction, diagnosis, and treatment. Prominent preoperative risk factors include patient demographics (older age, male sex, elevated body mass index), comorbid conditions (heart failure with reduced ejection fraction, chronic kidney disease, anemia, infective endocarditis, hemodynamic instability, thyroid dysfunction, diabetes mellitus, tobacco use), medications (renin-angiotensin-aldosterone axis blockers, calcium channel blockers, beta-blockers, inotropes, antiplatelets and anticoagulants, amiodarone, diuretics, anesthetic agents), and the type of surgical procedure performed. Prominent intraoperative risk factors include the use of cardiopulmonary bypass, blood product transfusion, and poor temperature control. Multiple biomarkers and dynamic monitoring systems are being studied as predictors for the development of vasoplegia. An overview of available treatments is presented along with up-to-date evidence supporting their use in multimodal vasopressor regimens.
引用
- Awad AS, Mangold AS, Ainechi A, et al. Causes, Predictors, and Treatment of Vasoplegia in Cardiac Surgery: A Narrative Review. Anesth Analg. 2026. PMID: 42268652. doi:10.1213/ANE.0000000000008086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。